Phase 2 clinical study for patients with dcSSc or PAH
The American company, Cumberland Pharmaceuticals, is conducting a phase 2 clinical study evaluating the safety and effectiveness of a new oral drug product.
Recent news
News archive
- March 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- November 2019
- June 2019
- April 2019
- February 2019
- September 2018
- June 2018
- May 2018
- April 2018
- March 2018
- December 2017
- May 2017
- November 2016
- September 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- November 2015
- October 2015
- September 2015
- July 2015
- May 2015
- March 2015
- February 2015
- November 2014
- September 2014
- July 2014
- June 2014
- May 2014
- March 2014
- February 2014
- December 2013
- June 2013
- April 2013
- March 2013
- February 2013
- June 2009